Status:
COMPLETED
Moxibustion for Fetus in Breech Presentation
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
Swiss National Science Foundation
Loterie Romande
Conditions:
Breech Presentation
Eligibility:
FEMALE
Phase:
PHASE3
Brief Summary
Objective: To evaluate moxibustion of the BL67 acupoint between 34 and 38 weeks of gestation to facilitate cephalic version of breech presentation in a Western setting. The hypothesis is that moxibust...
Eligibility Criteria
Inclusion
- Breech presentation
- 34 to 36 weeks of gestation
- Single fetus
Exclusion
- Uterine malformation
- Placenta praevia
- Transverse lie
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT00890474
Start Date
October 1 2004
End Date
January 1 2009
Last Update
April 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires de Genève
Geneva, Switzerland